Evidence map›Paper›PMID 32277033›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

Structural and kinetic basis for the regulation and potentiation of Hsp104 function.

Xiang Ye, JiaBei Lin, Leland Mayne, James Shorter, S Walter Englander

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. State-of-the-Art and Future Directions in Structural Proteomics.Molecular & cellular proteomics : MCP · 2025
    Review
  4. Article
  5. Article
  6. Design principles to tailor Hsp104 therapeutics.bioRxiv : the preprint server for biology · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. AAA+ proteins: one motor, multiple ways to work.Biochemical Society transactions · 2022
    Review
  11. Article
  12. Drivers of Hsp104 potentiation revealed by scanning mutagenesis of the middle domain.Protein science : a publication of the Protein Society · 2021
    Article
  13. (Dis)Solving the problem of aberrant protein states.Disease models & mechanisms · 2021
    Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xiang YeJohnson Research Foundation, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19355; xiangye@pennmedicine.upenn.edu engl@pennmedicine.upenn.edu.ORCID 0000-0003-3117-3484
JiaBei LinDepartment of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19355.
Leland MayneJohnson Research Foundation, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19355.
James ShorterDepartment of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19355.ORCID 0000-0001-5269-8533
S Walter EnglanderJohnson Research Foundation, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19355; xiangye@pennmedicine.upenn.edu engl@pennmedicine.upenn.edu.ORCID 0000-0002-4802-2175

Funding

Protein structure and function by hydrogen exchange mass spectrometry analysisR01GM031847 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI ENGLANDER, S. WALTER · 1985 to 2017
$6.3M
Defining the mechanistic basis of a prion disaggregaseR01GM099836 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI SHORTER, JAMES · 2013 to 2024
$3.9M
NIGMS NIH HHS R01 GM031847NIGMS NIH HHS R01 GM099836
6 · The paper itself

Abstract

Hsp104 provides a valuable model for the many essential proteostatic functions performed by the AAA+ superfamily of protein molecular machines. We developed and used a powerful hydrogen exchange mass spectrometry (HX MS) analysis that can provide positionally resolved information on structure, dynamics, and energetics of the Hsp104 molecular machinery, even during functional cycling. HX MS reveals that the ATPase cycle is rate-limited by ADP release from nucleotide-binding domain 1 (NBD1). The middle domain (MD) serves to regulate Hsp104 activity by slowing ADP release. Mutational potentiation accelerates ADP release, thereby increasing ATPase activity. It reduces time in the open state, thereby decreasing substrate protein loss. During active cycling, Hsp104 transits repeatedly between whole hexamer closed and open states. Under diverse conditions, the shift of open/closed balance can lead to premature substrate loss, normal processing, or the generation of a strong pulling force. HX MS exposes the mechanisms of these functions at near-residue resolution.

Indexed as

Genetic VariationAdenosine TriphosphateAmino Acid SubstitutionGene Expression Regulation, FungalHeat-Shock ProteinsMutationProtein BindingSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsAdenosine TriphosphateHeat-Shock ProteinsHsP104 protein, S cerevisiaeSaccharomyces cerevisiae ProteinsAAA+HDX-MSHsp104HX MSmolecular machine

Identifiers

PMID32277033
PMCPMC7196772

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.